GeoVax Labs, Inc. (GOVX) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
GeoVax Labs, Inc.
Address
1900 Lake Park Drive
Smyrna, GA 30080
United States of America (the)
Phone
678 384 7220
Website
Sector
Healthcare
Industry
Biotechnology
Employees
19
First IPO Date
September 25, 2020
Key Executives
| Name | Title | Pay | Year Born |
| David Alan Dodd | Chairman, President & Chief Executive Officer | 387,695 | 1950 |
| Valerie C. Montgomery Rice FACOG | Special Advisor to the Chairman & CEO and Director | 0 | 1962 |
| Mark J. Newman | Chief Scientific Officer | 301,703 | 1955 |
| Mark W. Reynolds | Chief Financial Officer & Corporate Secretary | 348,200 | 1962 |
| Kelly T. McKee Jr. | Chief Medical Officer | 368,550 | 1950 |
| John W. Sharkey | Vice President of Business Development | 0 | 1956 |
| Jeffrey Welch | Head of Process Development & Manufacturing Operations | 0 | N/A |
| Thomas O'Brien | Vice President of Quality Systems & Compliance | 0 | N/A |
Description
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.
